Literature DB >> 6723908

The elimination of 1,5-anhydroglucitol administered to rats.

E Pitkänen, O Pitkänen.   

Abstract

Rat serum contains natural 1,5-anhydroglucitol. Injected or orally administered 1,5-anhydroglucitol was efficiently reabsorbed by the renal tubuli via a mechanism which had a saturation point at high serum 1,5- anhydroglucitol levels. The compound had a slow turnover rate in the body; its half-life is approximately 3 days. The compound was readily absorbed in the gut when administered orally.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6723908     DOI： 10.1007/BF01952387

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  5 in total

1.  Occurrence of I,5-anhydroglucitol in human cerebrospinal fluid.

Authors:  E Pitkänen
Journal:  Clin Chim Acta       Date:  1973-10-12       Impact factor: 3.786

2.  Gas-chromatographic determination of polyol profiles in cerebrospinal fluid.

Authors:  S L Smith; M Novotny; E L Weber
Journal:  Clin Chem       Date:  1978-04       Impact factor: 8.327

3.  Feeding and hyperglycemia induced by 1,5-anhydroglucitol in the rat.

Authors:  T Sakata; K Tsutsui; M Fukushima; K Arase; H Kita; Y Oomura; K Ohki; S Nicolaidis
Journal:  Physiol Behav       Date:  1981-09

4.  Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.

Authors:  C Servo; E Pitkänen
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

5.  Serum 1,5-anhydroglucitol in normal subjects and in patients with insulin-dependent diabetes mellitus.

Authors:  E Pitkänen
Journal:  Scand J Clin Lab Invest       Date:  1982-09       Impact factor: 1.713
  5 in total
  6 in total

1.  Renal tubular reabsorption of 1,5-anhydro-D-glucitol and D-mannose in vivo in the rat.

Authors:  E Pitkänen; O M Pitkänen
Journal:  Pflugers Arch       Date:  1992-03       Impact factor: 3.657

2.  Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.

Authors:  T Yamanouchi; H Akanuma; T Nakamura; I Akaoka; Y Akanuma
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

3.  Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Authors:  S P Juraschek; E R Miller; L J Appel; R H Christenson; F M Sacks; E Selvin
Journal:  Diabet Med       Date:  2017-07-09       Impact factor: 4.359

4.  Plasma 1,5-anhydroglucitol in experimental galactosemia in the rat.

Authors:  E Pitkänen; O M Pitkänen
Journal:  Experientia       Date:  1990-01-15

5.  Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients.

Authors:  Y Akanuma; M Morita; N Fukuzawa; T Yamanouchi; H Akanuma
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

6.  Alternative markers of hyperglycemia and risk of diabetes.

Authors:  Stephen P Juraschek; Michael W Steffes; Edgar R Miller; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2012-08-08       Impact factor: 19.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.